ProfileGDS5678 / 1435757_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 98% 98% 98% 98% 98% 97% 98% 98% 98% 98% 98% 98% 98% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 19.9806298
GSM967853U87-EV human glioblastoma xenograft - Control 210.092398
GSM967854U87-EV human glioblastoma xenograft - Control 310.249198
GSM967855U87-EV human glioblastoma xenograft - Control 410.301398
GSM967856U87-EV human glioblastoma xenograft - Control 59.9666398
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 19.6633398
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 29.3906397
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 39.8485398
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 410.057998
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 19.9917698
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 29.6985798
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.037698
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 49.8576498
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 59.9018498